Nisa Investment Advisors
AVBP icon

Nisa Investment Advisors’s ArriVent BioPharma AVBP Stock Holding History

Nisa Investment Advisors’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6K Buy
392
+79
+25% +$2.33K ﹤0.01% 2383
2026
Q1 		$7.22K Hold
313
– – ﹤0.01% 2349
2025
Q4 		$6.3K Hold
313
– – ﹤0.01% 2392
2025
Q3 		$5.78K Sell
313
-21
-6% -$413 ﹤0.01% 2409
2025
Q2 		$7.27K Buy
334
+307
+1,137% +$6.38K ﹤0.01% 2374
2025
Q1 		$499 Sell
27
-69
-72% -$1.69K ﹤0.01% 2794
2024
Q4 		$2.56K Buy
96
+69
+256% +$1.98K ﹤0.01% 2415
2024
Q3 		$635 Hold
27
– – ﹤0.01% 2680
2024
Q2 		$501 Buy
+27
New +$481 ﹤0.01% 2686

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nisa Investment Advisors's AVBP Position: Q2 2026 in Review

Nisa Investment Advisors increased its ArriVent BioPharma (AVBP) stake by 25% in Q2 2026, buying an estimated $2.33K and bringing the position to 392 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2383.

Nisa Investment Advisors first reported a position in AVBP in Q2 2024 and has held it in 9 quarters since. 157 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • Nisa Investment Advisors held 392 shares of ArriVent BioPharma worth $13.6K as of Q2 2026.
  • Nisa Investment Advisors bought 79 ArriVent BioPharma shares in Q2 2026, an estimated $2.33K.
  • ArriVent BioPharma made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2383 holding.
  • Nisa Investment Advisors first reported a position in ArriVent BioPharma in Q2 2024 and has held it in 9 quarters since.
  • 157 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.